C-2 (Liverpool Hospital)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameC-2 (Liverpool Hospital)
Drug Alias NamePLA2 inhibitor (Liverpool Hospital)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLiverpool Hospital
China Registration ClassN/A

Develop Information

Active CompaniesLiverpool Hospital
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A